Assistant Professor of Medicine, Brigham and Women's Hospital
Cardiology
Dr. Benjamin M. Scirica, MD
|
|
Give Review
Benjamin M. Scirica practices Cardiology. He researched medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received awards:"Fellow (FAHA)" and "Fellow (FACC)". Benjamin Scirica is a published doctor as well. He has 63 publications published. The latest was: Post-Hospital Outcomes of PatientsWithAcute Myocardial Infarction WithCardiogenic Shock: Findings From the NCDR. Doctor Benjamin M. Scirica, MD is registered with Medicare.
Publications
- Post-Hospital Outcomes of Patients With Acute Myocardial Infarction With Cardiogenic Shock: Findings From the NCDR.
- Incidence and predictors of incomplete revascularization in a contemporary cohort.
- Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50).
- Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or...
- Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.
- Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
- Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial.
- Evaluation of glucose management during therapeutic hypothermia at a Tertiary Academic Medical Center.
- Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothromb...
- Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials.
- Long-term management and unmet needs after an Acute coronary syndrome event.
- New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial.
- Metabolic Syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.
- Surgical Ineligibility and Mortality Among Patients with Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
- Effect of ranolazine on atrial fibrillation in patients with non-ST elevation Acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
- Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TI...
- ECG morphological variability in beat space for risk stratification after Acute coronary syndrome.
- Evaluating the efficacy of mineralocorticoid receptor antagonism in patients with STEMI without Heart failure.
- Coronary computed tomographic angiography in the emergency room: state of the art.
- Clinical Implications and Correlates of Q Waves in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY-TIMI 28 Tr...
- Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Sy...
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
- Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2{degrees}P-TIMI 50.
- Prevalence, incidence, and implications of silent Myocardial infarctions in patients with diabetes mellitus.
- Efficacy and safety of vorapaxar in patients with prior ischemic stroke.
- Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with Acute coronary syndromes.
- Potassium concentration and repletion in patients with Acute myocardial infarction.
- Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular Disease.
- Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial.
- The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus-Thrombolysis in Myocardial Infarction (SAVOR-TI...
- Computationally generated cardiac biomarkers for risk stratification after Acute coronary syndrome.
- Myocardial Ischemia and Ventricular Tachycardia on Continuous Electrocardiographic Monitoring and Risk of Cardiovascular Outcomes After Non-ST-Segment Elevation Acute ...
- Central obesity and cardiovascular outcomes in patients with Acute coronary syndrome: observations from the MERLIN-TIMI 36 trial.
- Effect of Prior Stroke on the Use of Evidence-Based Therapies and In-Hospital Outcomes in Patients With Myocardial Infarction (from the NCDR ACTION GWTG Registry).
- Ticagrelor versus clopidogrel in patients with Acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Pati...
- Implementation of a Hospital-wide Protocol for Induced Hypothermia Following Successfully Resuscitated Cardiac Arrest.
- Relationship between nonsustained ventricular tachycardia after non-ST-elevation Acute coronary syndrome and sudden cardiac death: observations from the metabolic effi...
- Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coron...
- Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation ...
- Clinical features and outcomes of women with unstable ischemic heart Disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevat...
- Acute coronary syndrome: emerging tools for diagnosis and risk assessment.
- B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation Acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metab...
- Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation Myocardial infarction.
- Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural Myocardial infarction in the Trial to Assess Improvement in Therap...
- Efficacy of ranolazine in patients with chronic Angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranola...
- Ischemia detected on continuous electrocardiography after Acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less ...
- Relation of death within 90 days of non-ST-elevation Acute coronary syndromes to variability in electrocardiographic morphology.
- Chronic Angina: definition, prevalence, and implications for quality of life.
- Effect of ranolazine, an antiAnginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute ...
- Ranolazine in patients with Angina and coronary artery disease.
- Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous Coronary intervention in patien...
- The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation Myocardial infarction: the ECG CLARITY-TIMI 28 Study.
- Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.
- Appropriate invasive and conservative treatment approaches for patients with non-ST-elevation MI.
- Treatment of elevated cholesterol.
- Influence of race on death and ischemic complications in patients with non-ST-elevation Acute coronary syndromes despite modern, protocol-guided treatment.
- Troponins in Acute coronary syndromes.
- Assessing the effect of publication of clinical guidelines on the management of unstable Angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) ...
- Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable Angina pectoris and non-ST-elevation myocardial infarction in the TIMI III regis...
- Efficacy and safety of vorapaxar as approved for clinical use in the United States.
- The Clinical Significance of Continuous ECG (Ambulatory ECG or Holter) Monitoring of the ST-Segment to Evaluate Ischemia: A Review.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FAHA)
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1982664033 | |
| NPPES Provider LastName | SCIRICA | |
| NPPES Provider FirstName | BENJAMIN | |
| NPPES Provider ZIPCode | 021156110 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 499.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982664033 |
| Last Name Of The Provider | SCIRICA |
| First Name Of The Provider | BENJAMIN |
| View All |
Similar Doctors
|
|
Dr. James E. Muller, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajeev Malhotra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishna G. Aragam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley A. Maron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yamini S. Levitzky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Kang, MD |
|
|
Dr. Roger J. Laham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Eric Josephson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Venkatesan D. Vidi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Harthorne, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Wilson S. Colucci, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roberta Florido, MD |